Highly Validated Growth Factors/Cytokines Driving Advances in Organoid Research
Unleashing Full Potential of iPSC Derived Allogeneic Cell Therapies
Utilizing GMP-Grade Laminin for Scalable Manufacturing of iPSC-Derived Cell Therapies
Universal CAR-NK Cell Therapy: The Promising Future of Targeted Cancer Immunotherapy
ACROBiosystems are going full steam ahead on developing a collection of recombinant antigens for emergency SARS-CoV-2 variants. The reagents can be used to evaluate the efficacy of the antibodies and vaccination.
ACROBiosystems developed a series of GMP grade cytokines under the GMP grade quality management system. Those products are all suitable for T/NK cell generation, activation, and proliferation in cell therapy research.
This web search service is supported by Google Inc.
Leave a like or
share your feedback!
6799